Cc1cc(NC(=O)C2C3C(=O)N(c4cccnc4)C(C(=O)NC(C)(C)C)C34C=CC2(C)O4)no1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?